Tea: Age-old beverage as an effective cancer chemopreventive agent

Oncology Reviews

Volumn 1, Issue 4, 2008, Pages 243-252

  George, Jasmine ^a   Nigam, Nidhi ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Cancer; Chemoprevention; Epidemiology; Polyphenols; Tea

Indexed keywords

EID: 78650929463     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-008-0029-5     Document Type: Review

References (89)

1. Watson W, Cai J, Jones D (2000) Diet and apoptosis. Annu Rev Nutr 108:153-164
2. Wenzel U, Kuntz S, Brendel M, Daniel H (2000) Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 60:3823-3831 (Pubitemid 32204574)
3. Yang C, Landau J, Huang M, Newmark H (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21:381-397
4. Sporn MB, Suh N (2002) Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2:537-543 (Pubitemid 37328935)
5. Khan N, Mukhtar H (2007) Tea polyphenols for health promotion. Life Sci 81:519-533 (Pubitemid 47212236)
6. Balentine DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37:693-704 (Pubitemid 127349613)
7. Stoner GD, Mukhtar H (1995) Polyphenols as cancer chemopreventive agents. J Cell Biochem 22:169-180
8. Mukhtar H, Ahmad N (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71:1698S-1702S
9. Yang CS, Wang ZY (1993) Tea and cancer. J Natl Cancer Inst 85:1038-1049 (Pubitemid 23199184)
10. Katiyar SK (2003) Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr Drug Targets Immune Endocr Metabol Disord 3:234-242
11. Yang CS, Lee MJ, Chen L, Yang GY (1997) Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect 105:971-976 (Pubitemid 27372990)
12. Khan N, Afaq F, Saleem M et al (2006) Targeting multiple signaling pathways by green tea polyphenol (-) - epigallocatechin-3-gallate. Cancer Res 66:2500-2505
13. Wiseman SA, Balentine DA, Frei B (1997) Antioxidants in tea. Crit Rev Food Sci Nutr 37:705-718 (Pubitemid 127348897)
14. Goldbohm R, Hertog M, Brants H et al (1996) Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88:93-100 (Pubitemid 26020097)
15. Tsubono Y, Nishino Y, Komatsu S et al (2001) Green tea and the risk of gastric cancer in Japan. N Engl J Med 344:632-636 (Pubitemid 32183578)
16. Tsubono Y, Tsugane S, Gey KF (1999) Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. Nutr Cancer 34:56-61 (Pubitemid 29382916)
17. Arts I, Holmann P, Bueno de Mesquita H et al (2001) Dietary catechins and epithelial cancer incidence: the Zutphen Elderly Study. Int J Cancer 92:298-302 (Pubitemid 32225384)
18. Garcia-Closas R, Agudo A, Gonzalez C, Riboli E (1998) Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer 32:154-158 (Pubitemid 29081402)
19. Arts I, Jacobs Jr D, Gross M et al (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control 13:373-382 (Pubitemid 34553518)
20. De Stefani E, Roncoa A, Mendilaharsu M, Deneo-Pellegrini H (1999) Diet and risk of cancer of the upper aerodigestive tract: II. Nutrients. Oral Oncol 35:22-26 (Pubitemid 28546840)
21. Garcia-Closas R, Gonzalez C, Agudo A, Riboli E (1999) Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10:71-75 (Pubitemid 29134755)
22. Su L, Arab L (2002) Tea consumption and the reduced risk of colon cancer -results from a national prospective cohort study. Public Health Nutr 5:419-425 (Pubitemid 34614909)
23. Le Marchand L, Murphy S, Hankin J et al (2000) Intake of flavonoids and lung cancer. J Natl Cancer Inst 92:154-160 (Pubitemid 30089873)
24. Nakachi K, Suemasu K, Suga K et al (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89:254-261 (Pubitemid 28197289)
25. Lambert JD, Yang CS (2003a) Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 523-524:201-208 (Pubitemid 36293247)
26. Lambert JD, Yang CS (2003b) Mechanisms of cancer prevention by tea constituents. J Nut 133:3262S-3267S (Pubitemid 37222254)
27. Jian L, Xie LP, Lee AH, Binns CW (2004) Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 108:130-135 (Pubitemid 37444455)
28. Sueoka N, Suganuma M, Sueoka E et al (2001) A new function of green tea: prevention of lifestyle-related diseases. Ann N YAcad Sci 928:274-280 (Pubitemid 32386088)
29. Katiyar SK, Elmets CA (2001) Green tea polyphenolic antioxidants and skin photoprotection. Int J Oncol 18:1307-1313
30. SK Mantena, SM Meeran, CA Elmets, SK Katiyar (2005) Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J Nutr 135:2871-2877 (Pubitemid 43156556)
31. Javed S, Mehrotra NK, Shukla Y (1998) Chemopreventive effects of black tea polyphenols in mouse skin model of carcinogenesis. Biomed Environ Sci 11307-11313
32. Katiyar SK, Afaq F, Perez A, Mukhtar H (2001) Green tea polyphenol (-) -epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22:287-294 (Pubitemid 32175517)
33. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H (2001) Inhibition of UVBinduced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-) -epigallocatechin-3-gallate. Toxicol Appl Pharmacol 176:101-107
34. Afaq F, Adhami VM, Ahmad N, Mukhtar H (2003) Green tea constituent (-) - epigallocatechin-3-gallate inhibits ultraviolet B-mediated activation of nuclear factor kappa B signaling pathway in normal human epidermal keratinocytes. Oncogene 22:1035-1044 (Pubitemid 36313147)
35. Hakim IA, Harris RB (2001) Joint effects of citrus peel use and black tea intake on the risk of squamous cell carcinoma of the skin. BMC Dermatology 1:3
36. Kalra N, Prasad S, Shukla Y (2005) Antioxidant potential of black tea against 7,12-dimethylbenz(a) anthracene-induced oxidative stress in Swiss albino mice. J Environ Pathol Toxicol Oncol 24:105-114
37. Nakachi K, Matusuyama S, Miyake S et al (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13:49-54 (Pubitemid 32107344)
38. Sozzi G, Miozzo M, Donghi R et al (1992) Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079-6082
39. Xu Y, Ho CT, Amin SG et al (1992) Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res 52:3875-3879
40. Wang ZY, Agarwal R, Khan WA, Mukhtar H (1992) Protection against benzo[a]pyrene- and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice. Carcinogenesis 13:1491-1494
41. Wang ZY, Huang MT, Ho CT et al (1992) Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 52:6657-6665
42. Xu Y, Ho CT, Amin SG et al (1992) Inhibition of tobacco specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Research 52:3875-3879
43. Liao J, Yang GY, Park ES et al (2004) Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer 48:44-53 (Pubitemid 38823545)
44. Landau JM, Wang ZY, Yang GY et al (1998) Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis 19:501-507 (Pubitemid 28375454)
45. Shay J, Wright W (2006) Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Disc 5:577-584 (Pubitemid 43971192)
46. Sadava D, Whitlock E, Kane SE (2007) The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun 360:233-237 (Pubitemid 46994711)
47. Banerjee S, Manna S, Saha P (2005) Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo (a)pyrene-induced lung carcinogenesis. European Journal of Cancer Prevention 14:215-221 (Pubitemid 40780444)
48. Parkin D, Muir C (1992) Cancer incidence in five continents: comparability and quality of data. IARC Sci Publ 120:45-173
49. Leung LK, Su Y, Chen R et al (2001) Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 131:2248-2251 (Pubitemid 32851864)
50. Chen CW, Ho CT (1995) Antioxidant properties of polyphenols extracted from green and black teas. J Food Lipids 2:35-46
51. Pryor WA (1986) Cancer and free radicals. Basic Life Sci 39:45-59
52. Bartsch H, Nair J (2004) Oxidative stress and lipid peroxidation derived DNA lesions in inflammation driven carcinogenesis. Cancer Detect PreV 28: 385-391 (Pubitemid 39568933)
53. Wu AH, Yu MC, Tseng CC et al (2003) Green tea and risk of breast cancer in asian americans. Int J Cancer 106:574-579 (Pubitemid 36966216)
54. Zhou JR, Yu L, Mai Z, Blackburn GL (2004) Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 108:8-14 (Pubitemid 37444437)
55. Rogers AE, Hafer LJ, Iskander YS, Yang CS (1998) Black tea and mammary gland carcinogenesis by 7, 12-dimethylbenz-[a]anthracene in rats fed control or high fat diets. Carcinogenesis 19:1269-1273 (Pubitemid 28375379)
56. Weisburger JH, Rivenson A, Garr K, Aliaga C (1997) Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett 114:323-327 (Pubitemid 27140143)
57. Green JE, Shibata MA, Yoshidome K et al (2000) The C3 (1)/SV40 T antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19:1020-1027 (Pubitemid 30153785)
58. Leong H, Mathur PS, Greene GL (2008) Inhibition of mammary tumorigenesis in the C3 (1)/SV40 mouse model by green tea. Breast Cancer Res Treat 107:359-369 (Pubitemid 351172119)
59. Baliga MS, Meleth S, Katiyar SK (2005) Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin Cancer Res 11:1918-1927 (Pubitemid 40471858)
60. Thangapazham RL, Passi N, Maheshwari RK (2007) Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast Cancer Cells. Cancer Biol Ther 6
61. Klein EA (2005) Can prostate cancer be prevented? Nat Clin Pract Urol 2:24-31 (Pubitemid 40823151)
62. Sonn GA, Aronson W, Litwin MS (2005) Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis 8:304-310 (Pubitemid 43078163)
63. Ahmad N, Feyes DK, Nieminen AL (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89:1881-1886 (Pubitemid 28009824)
64. Paschka AG, Butler R, Young CY (1998) Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130:1-7 (Pubitemid 28425331)
65. Lyn-cook BD, Rogers T, Yan Y et al (1999) Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer 35:80-86
66. Gingrich JR, Barrios RJ, Morton RA et al (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096-4102 (Pubitemid 26304996)
67. Gingrich JR, Barrios RJ, Kattan MW et al (1997) Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 57:4687-4691 (Pubitemid 27468967)
68. Gupta S, Hastak K, Ahmad N et al (2001) Inhibition of prostate carcinogenesis in TRAMP mice by I oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98:10350-10355 (Pubitemid 32803023)
69. Koivisto P, Visakorpi T, Rantala I, Isola J (1997) Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer. J Pathol 183:51-56 (Pubitemid 27368526)
70. Koivisto P, Hyytinen E, Palmberg C et al (1995) Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy. Am J Pathol 147:1608-1614
71. Taplin ME, Bubley GJ, Shuster TD et al (1995) Mutation of the androgenreceptor gene in metastatic androgenindependent prostate cancer. N Engl J Med 332:1393-1398
72. Kao YH, Hiipakka RA, Liao S (2000) Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141:980-987 (Pubitemid 32260441)
73. Webber MM, Waghray A, Bello D (1995) Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1:1089-1094
74. Di Silverio F, Sciarra A, Monti S et al (1999) Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia? J Urol 161:128-132 (Pubitemid 29422306)
75. Pezzato E, Sartor L, Dell'Aica I et al (2004) Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-) epigallocatechin-3-gallate. Int J Cancer 112:787-792 (Pubitemid 39435263)
76. Kalra N, Seth K, Prasad S et al (2007) Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways. Life Sci 80:2137-2146 (Pubitemid 46755334)
77. Lee JS, Chu IS, Heo J et al (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40:667-676 (Pubitemid 39265589)
78. Gong Y, Han C, Chen J (2000) Effect of tea polyphenols and tea pigments on the inhibition of precancerous liver lesions in rats. Nutr Cancer 38:81-86 (Pubitemid 32377947)
79. Nishikawa T, Nakajima T, Moriguchi M et al (2006) A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 44:1074-1082
80. Gong Y, Han C, Chen J (1999) Inhibitory effects of tea polyphenols and tea pigments on liver precancerous lesions in rats. Wei Sheng Yan Jiu 28:294-296
81. Mu LN, Zhou XF, Ding BG et al (2003) A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Zhonghua Liu Xing Bing Xue Za Zhi 24:192-195
82. Oguni I, Chen SJ, Lin PZ, Hara Y (1992) Protection against cancer risk by Japanese green tea. Prevent Med 21:332
83. Wang ZY, Hong JY, Huang MT et al (1992) Inhibition of N-nitrosodiethylamine and 4-(methylnitrosamino)-1 -(3-pridyl)- 1 -butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52:1943-1947
84. Yamane T, Nakatani H, Kikuoka N (1996) Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer 77:1662-1667 (Pubitemid 26111849)
85. Suganuma M, Ohkura Y, Okabe S, Fujiki H (2001) Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J Cancer Res Clin Oncol 127:69-72
86. Caderni G, De Filippo C, Luceri C (2000) Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis 21:1965-1969
87. Wang M, Guo C, Li M (1999) A casecontrol study on the dietary risk factors of upper digestive tract cancer. Zhonghua Liu Xing Bing Xue Za Zhi 20:95-97
88. Ju J, Hong J, Zhou JN (2005) Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 65:10623-10631 (Pubitemid 41743758)
89. Shimizu M, Deguchi A, Lim JT et al (2005) (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11:2735-2746 (Pubitemid 40569476)